Wave Computing to Present Details of Ground-Breaking “SAT Solver” Technology at ICCAD 2017
Nov 13, 2017 13:00 pm UTC| Business
CAMPBELL, Calif., Nov. 13, 2017 -- Wave Computing™, the Silicon Valley start-up that is revolutionizing artificial intelligence and deep learning with its dataflow-based solutions, today announced Dr. Samit Chaudhuri...
Nov 13, 2017 13:00 pm UTC| Business
NEW YORK, Nov. 13, 2017 -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, announced that Andrew Satlin...
Clinical Genomics and Quest Diagnostics announce FDA 510(K) clearance of InSure® ONE™
Nov 13, 2017 13:00 pm UTC| Business
At-home collection, one-day fecal immunochemical test that meets American Cancer Society guidelines and HEDIS quality measures for lower gastrointestinal bleeding screening programs A number of medical conditions may be...
Iovance Biotherapeutics to Present at the Jefferies 2017 London Healthcare Conference
Nov 13, 2017 13:00 pm UTC| Business
SAN CARLOS, Calif., Nov. 13, 2017 -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced...
Nov 13, 2017 13:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Nov. 13, 2017 -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) announced today that the independent Data and Safety Monitoring Board (DSMB) for the Phase 3 HOPE (Hemoglobin Oxygen...
Tyme to Present at Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference
Nov 13, 2017 13:00 pm UTC| Business
NEW YORK, Nov. 13, 2017 -- Tyme Inc. (Nasdaq:TYME), a biotechnology company using cellular metabolism and oxidative stress to develop cancer therapeutics, today announced that Jonathan Eckard, Chief Scientific Affairs...
Fibrocell Reports Third Quarter 2017 Financial Results and Recent Highlights
Nov 13, 2017 13:00 pm UTC| Business
EXTON, Pa., Nov. 13, 2017 -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today reported financial...